Forum Alert: Biosante Pharmaceuticals, Inc. Will Present at the Informed Investors Biotechnology / Healthcare / Pharmaceutical I

Biosante Pharmaceuticals, Inc. (AMEX: BPA) will present
at the following forum:
-0-
*T
What:  Informed Investors Biotechnology / Healthcare / Pharmaceutical 
       Investor Forum

When:     June 15, 2005 @ 1:25 PM Eastern Time

Sponsors:  Barron's, The Wall Street Journal, The American Stock 
           Exchange and Business Wire

Keynote Presentations:  Lynn Sutherland, M.S., M.B.A. - President, 
                        Sutherland Consulting Dr. Navdeep Jaikaria, 
                        Senior Biotechnology Analyst, Rodman &
                        Renshaw, LLC

Where:   The Princeton Club of New York, 15 West 43rd Street., New 
         York City, NY 10036

How to attend:  Pre-registration is necessary.  To register, contact 
Cary Loeser, [e-mail], or 804-327-3407.   You may also call 
Customer Service at 888-301-6618, or register at the following link:
http://www.informedinvestors.com/CustomEvent/89559/index.asp

If you are unable to attend the live event, the forum will be 
available via webcast at
http://www.informedinvestors.com/CustomEvent/89559/index.asp

Contact: Phillip Donenberg, Chief Financial Officer, [phone], 
[e-mail]
*T
   BioSante is developing a pipeline of hormone therapy products to
treat both men and women. These hormone therapy products are gel
formulations for transdermal administration that deliver bioidentical
estradiol and testosterone. BioSante's lead products include
Bio-E-Gel(TM) (bioidentical estradiol gel) for the treatment of women
with menopausal symptoms, and LibiGel(TM) (bioidentical testosterone
gel) for the treatment of female sexual dysfunction (FSD). The current
market in the U.S. for estrogen and testosterone products is
approximately $2.5 billion. The company also is developing its calcium
phosphate nanotechnology (CAP) for novel vaccines, including
biodefense vaccines for toxins such as anthrax and ricin, and drug
delivery systems. Additional information is available online at
www.biosantepharma.com.